MedTrace Logo

Intercostal Nerve Block for Pain Management After Uniportal Video-assisted Thoracoscopic Surgeries

NCT06838026 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-04-01

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the safety and effectiveness of the three intercostal nerve blocks used in pain management in uniportal (one port) thoracoscopic surgeries: internal intercostal nerve blocks (ICNB), external ICNB, and Intercostal catheters.

Participants will be randomly assigned to three groups:

* First group will undergo internal intercostal nerve block
* Second group will be given external intercostal nerve block
* Third group will have an intercostal catheter Researchers will compare the three groups to see their impact on post-operative pain management in uniportal VATS.

Conditions

  • Thoracic
  • Pain, Postoperative
  • Analgesia
  • Satisfaction, Patient

Interventions

OTHER

External Intercostal Nerve Block

External ICNB: A mixture of analgesics will be given through a needle inserted in the intercostal space from outside the chest wall.

OTHER

Internal Intercostal Nerve Block

Internal ICNB: A mixture of analgesics will be given through a needle inserted in the intercostal space inside the chest wall under direct thoracoscopic vision.

OTHER

Intercostal Catheter

Intercostal Catheter: it will be put 1-2 intercostal spaces above the VATS incision, and the participant will receive the 15 cc of the previously mentioned mixture every 8 hours for two to three days.

Sponsors & Collaborators

  • Al-Ahli Hospital, Hebron

    collaborator UNKNOWN

  • Saint Joseph Hospital, East Jerusalem

    collaborator UNKNOWN

  • Al-Quds University

    lead OTHER

Principal Investigators

  • Yousef Abu Asabeh, M.D. · Thoracic Surgery Department, Al-Ahli Hospital, Palestine

  • Mayar Idkedek, M.D. · Medical Research Club, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine

  • Tabarak Al-Masri, M.D. · Medical Research Club, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2026-05-05
Completion
2026-12-05

Countries

  • Palestinian Territories

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06838026 on ClinicalTrials.gov